BART BURDICK: Open Payments
NPI 1063815546 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 11 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $260 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $235 |
| Vanda Pharmaceuticals Inc. | 4 | $144 |
| Viatris Specialty LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
Products named: NUPLAZID, FANAPT, YUPELRI, INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across OK — which companies pay providers there.
